TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 40nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 43.7nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 51.8nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 56nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 65nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 77.4nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 93.8nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 145nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 150nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 153nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 162nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 171nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 175nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 207nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 208nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 236nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 247nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 260nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 273nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 280nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 281nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 306nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 330nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 337nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 350nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 351nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 375nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 413nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 487nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 488nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 491nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 534nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 593nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 637nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 644nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 644nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 658nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 789nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 808nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 904nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 922nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 3.68E+3nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 3.86E+3nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 5.42E+3nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics
US Patent
Pharmasum Therapeutics
US Patent
Affinity DataIC50: 5.64E+3nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair